Luz Del Carmen Alarcon-Romero
Overview
Explore the profile of Luz Del Carmen Alarcon-Romero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
366
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Catalan-Castorena O, Garibay-Cerdenares O, Illades-Aguiar B, Rodriguez-Ruiz H, Zubillaga-Guerrero M, Leyva-Vazquez M, et al.
Heliyon
. 2024 Aug;
10(15):e34999.
PMID: 39170128
High-risk human papillomavirus (HR-HPV) is associated with the development of different types of cancer, such as cervical, head and neck (including oral, laryngeal, and oropharyngeal), vulvar, vaginal, penile, and anal...
2.
Catalan-Castorena O, Garibay-Cerdenares O, Illades-Aguiar B, Castillo-Sanchez R, Zubillaga-Guerrero M, Leyva-Vazquez M, et al.
Cancers (Basel)
. 2024 Jun;
16(12).
PMID: 38927930
HPV 16 integration is crucial for the onset and progression of premalignant lesions to invasive squamous cell carcinoma (ISCC) because it promotes the amplification of proto-oncogenes and the silencing of...
3.
Barrios-Palacios D, Organista-Nava J, Balandran J, Alarcon-Romero L, Zubillaga-Guerrero M, Illades-Aguiar B, et al.
Int J Mol Sci
. 2024 Jan;
25(1).
PMID: 38203290
Acute lymphoblastic leukemia (ALL) is the most common cancer in children worldwide. Although ALL patients' overall survival rates in wealthy countries currently surpass 80%, 15-20% of patients still experience relapse....
4.
Rodriguez-Nava C, Ortuno-Pineda C, Illades-Aguiar B, Flores-Alfaro E, Leyva-Vazquez M, Parra-Rojas I, et al.
Biomedicines
. 2023 Jun;
11(6).
PMID: 37371712
Monoclonal antibodies are among the most effective tools for detecting tumor-associated antigens. The U.S. Food and Drug Administration (FDA) has approved more than 36 therapeutic antibodies for developing novel alternative...
5.
Cortes-Sarabia K, Alarcon-Romero L, Mendoza-Catalan M, Carpio-Pedroza J, Castaneda-Saucedo E, Ortuno-Pineda C
Medicina (Kaunas)
. 2023 Mar;
59(3).
PMID: 36984538
REST (RE1-silencing transcription factor) diminution is associated with transcriptional relaxation, neuropeptide overexpression, and phenotype redefinition in neuroendocrine cancers, but this effect has barely been studied in cervical cancer (CC). We...
6.
Gomez-Gomez Y, Organista-Nava J, Clemente-Perivan S, Lagunas-Martinez A, Salmeron-Barcenas E, Villanueva-Morales D, et al.
Mol Biol Rep
. 2022 Nov;
50(2):981-991.
PMID: 36378419
Purpose: Oct3/4 a transcription factor is involved in maintaining the characteristics of cancer stem cells. Oct3/4 can be expressed differentially with respect to the progression of cervical cancer (CC). In...
7.
Perez-Bacho E, Beltran-Anaya F, Arechaga-Ocampo E, Hernandez-Sotelo D, Garibay-Cerdenares O, Illades-Aguiar B, et al.
Viruses
. 2022 May;
14(5).
PMID: 35632705
The E6 oncoprotein of HPV16 variants differentially alters the transcription of the genes involved in migration and non-coding RNAs such as lncRNAs. The role of the lncRNA MINCR in cervical...
8.
Alarcon-Romero L, Organista-Nava J, Gomez-Gomez Y, Ortiz-Ortiz J, Hernandez-Sotelo D, Del Moral-Hernandez O, et al.
Cancer Control
. 2022 May;
29:10732748221103331.
PMID: 35608056
Background: Cervical cancer (CC) is the fourth most common malignancy of the female genital tract. Human Papillomavirus (HPV) is the main cause of precancerous lesions and CC cases worldwide. Objective:...
9.
Cortes-Sarabia K, Alarcon-Romero L, Flores-Alfaro E, Illades-Aguiar B, Vences-Velazquez A, Mendoza-Catalan M, et al.
Biomed J
. 2022 May;
44(6 Suppl 2):S171-S178.
PMID: 35491677
Background: The repressor element 1-silencing transcription factor (REST) is a regulator of gene expression, and the Ras association domain family member 1 A (RASSF1A) is an important tumor suppressor gene...
10.
Cahua-Pablo J, Gomez-Zamudio J, Resendiz-Abarca C, Tello-Flores V, Eulogio-Metodio Y, Ramirez-Vargas M, et al.
Lipids
. 2021 Dec;
57(2):105-114.
PMID: 34927264
Dyslipidemia is the main risk factor for coronary artery disease and is characterized by alterations in concentrations of lipids, including low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), and triacylglycerols....